The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 348, doi. 10.1007/s11899-016-0335-0
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2016 AND VI 11 AND IP 5
Results: 7
1
2
How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 356, doi. 10.1007/s11899-016-0311-8
- By:
- Publication type:
- Article
3
Investigation and Management of Erythrocytosis.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 342, doi. 10.1007/s11899-016-0334-1
- By:
- Publication type:
- Article
4
Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 368, doi. 10.1007/s11899-016-0336-z
- By:
- Publication type:
- Article
5
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 385, doi. 10.1007/s11899-016-0337-y
- By:
- Publication type:
- Article
6
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 333, doi. 10.1007/s11899-016-0338-x
- By:
- Publication type:
- Article
7
What Is the Optimal Induction Therapy for Younger Fit Patients With AML?
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 327, doi. 10.1007/s11899-016-0339-9
- By:
- Publication type:
- Article